Clinical Focus

• Knee Replacement Arthroplasty
• Hip Replacement Arthroplasty
• Arthritis
• Orthopaedic Surgery
• Revision Hip and Knee Replacement Arthroplasty

Administrative Appointments

• Medical Director, Total Joint Replacement Center, Stanford Hospital and Clinics (2009 - present)
• Associate Residency Program Director, Department of Orthopaedic Surgery, Stanford University School of Medicine (2011 - present)

Honors and Awards

• Marshall R. Urist Award, Association of Bone and Joint Surgeons (2009)
• American Travelling Hip Fellow, British and American Hip Societies (2008)
• Young Investigator, Osteolysis and Implant Wear Symposium, Orthopaedic Research Society (2007)
• American Society of Clinical Pathologists' Award for Academic Excellence, University of Vermont College of Medicine (1996)

Professional Education

Graduate & Fellowship Program Affiliations

• Orthopedic Surgery

Community and International Work

• Kikuyu Orthopaedic Rehabilitation Centre, Kikuyu, Kenya 

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

My primary research interests include arthritis, clinical outcomes of primary and revision hip and knee replacement surgery, evaluation of the inflammatory cascade that leads to premature failure of hip and knee replacements, biomaterials, and the design of hip and knee implants and instrumentation.

Clinical Trials

• Evaluation of E-Poly (tm) and Regenerex (tm) Cementless Acetabular Components: Clinical and Radiographic Outcomes Recruiting

Publications

• Advanced Age and Comorbidity Increase the Risk for Adverse Events After Revision Total Hip Arthroplasty. Koenig K, Huddleston JI, Huddleston H, Maloney W, Goodman SB. J Arthroplasty. 2012
• Age and obesity are risk factors for adverse events after total hip arthroplasty. Huddleston JI, Wang Y, Uquillas C, Herndon JH, Maloney WJ. Clin Orthop Relat Res. 2012; 470 (2): 490-6
• Decreased length of stay after TKA is not associated with increased readmission rates in a national Medicare sample. Vorhies JS, Wang Y, Herndon JH, Maloney WJ, Huddleston JI. Clin Orthop Relat Res. 2012; 470 (1): 166-71
• Readmission and length of stay after total hip arthroplasty in a national Medicare sample. Vorhies JS, Wang Y, Herndon J, Maloney WJ, Huddleston JI. J Arthroplasty. 2011; 26 (6 Suppl): 119-23
• Aseptic versus septic revision total knee arthroplasty: patient satisfaction, outcome and quality of life improvement. Patil N, Lee K, Huddleston JI, Harris AH, Goodman SB. Knee. 2010; 17 (3): 200-3